What are the causes of high fecal calprotectin levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of High Fecal Calprotectin Levels

Elevated fecal calprotectin is primarily caused by inflammatory bowel disease (IBD), but can also be due to infectious gastroenteritis, colorectal cancer, and NSAID use, requiring appropriate diagnostic workup based on clinical presentation. 1, 2

Primary Causes of Elevated Fecal Calprotectin

  • Inflammatory Bowel Disease (IBD): Both Crohn's disease and ulcerative colitis consistently show significantly elevated calprotectin levels, with higher values correlating with disease activity and endoscopic inflammation 3, 4
  • Infectious Gastroenteritis: Acute bacterial, viral, or parasitic infections can cause significant elevation in fecal calprotectin, making it difficult to distinguish from IBD in acute presentations 2, 5
  • Colorectal Neoplasms: Colorectal cancer and advanced adenomas can elevate fecal calprotectin, though not as consistently or dramatically as IBD 3, 4
  • NSAID Use: Regular use of non-steroidal anti-inflammatory drugs within the past 6 weeks can cause elevated calprotectin levels due to drug-induced enteropathy 1

Interpretation of Elevated Calprotectin Levels

  • <50 μg/g: Generally considered normal with high negative predictive value for ruling out IBD 1
  • 50-100 μg/g: Mildly elevated, may represent non-specific low-grade inflammation 1
  • 100-250 μg/g: Moderately elevated, warrants consideration of repeat testing or routine referral to gastroenterology 1, 2
  • >250 μg/g: Significantly elevated, indicates need for urgent referral to gastroenterology and has better specificity (82%) for active IBD 3, 1

Clinical Approach to Elevated Calprotectin

For Patients with Acute Diarrhea:

  • Calprotectin will not reliably distinguish between IBD and infectious gastroenteritis 2
  • Stool culture and/or flexible sigmoidoscopy/colonoscopy are appropriate diagnostic investigations 3, 2

For Patients with Bloody Diarrhea:

  • Flexible sigmoidoscopy is indicated regardless of calprotectin result 2
  • In patients under 50 years, elevated calprotectin with bloody diarrhea strongly predicts IBD or colorectal cancer but does not discriminate between the two 3

For Patients with Suspected IBD:

  • Calprotectin correlates well with endoscopic inflammation in both ulcerative colitis and Crohn's disease 3, 6
  • In known IBD patients, elevated calprotectin can predict relapse, especially in ulcerative colitis 7
  • Post-operative elevation in Crohn's disease patients is indicative of disease recurrence 7

For Patients with Suspected Colorectal Cancer:

  • Calprotectin is not sensitive enough to exclude advanced colorectal adenoma or colorectal carcinoma 3
  • In patients with rectal bleeding, abdominal pain, change in bowel habit, weight loss, or iron-deficiency anemia, cancer pathway referral should be strongly considered rather than relying on calprotectin 3, 2

Important Considerations for Calprotectin Testing

  • First morning stool should be used for sampling 3
  • Samples should be stored for no more than 3 days at room temperature before analysis 3
  • Variability exists between different assays and even between different stool samples from the same patient 3
  • Repeat testing may be valuable in patients with initially elevated calprotectin (≥100 μg/g), as 53% show reduction upon retesting after approximately 18 days 3

Pitfalls in Interpretation

  • Calprotectin levels may not be significantly elevated when a pathogen is detected in patients with IBD (median 299 vs 255 mg/kg, P = 0.207) 5
  • The relationship between pathogen detection and calprotectin levels is nonlinear and varies by IBD status 5
  • Different patterns of mucosal inflammatory activity may explain why the association between raised calprotectin and relapse is not universal 7
  • Changes in calprotectin levels over time may be more predictive of disease activity than absolute values 7

References

Guideline

Calprotectin as a Biomarker for Intestinal Inflammation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Elevated Faecal Calprotectin in Acute Settings

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Role of faecal calprotectin as non-invasive marker of intestinal inflammation.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.